Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibrosin-like protein 1 (FBRSL1) is a member of the AUTS2 gene family, encoding a poorly characterized protein with RNA-binding activity, primarily important during embryonic development and neurodevelopment. FBRSL1 interacts with chromatin regulators and Polycomb group complexes, influencing transcriptional regulation and epigenetic processes. Mutations or truncations in FBRSL1 are linked to congenital malformation and intellectual disability syndromes. There is no current evidence linking "FBRSL1 pseudogene 1" to functional roles or therapeutic targeting. Pseudogenes generally may have regulatory roles, such as acting as miRNA sponges, but such effects are not documented for FBRSL1P1[1][2][3][4][5].
None known for drugs, as neither FBRSL1 nor FBRSL1P1 is an established drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FBRSL1 pseudogene 1 (FBRSL1P1).